全球肝病负担
慢性肝病及其并发症(肝硬化和肝癌)造成显著死亡、疾病和经济负担。世界卫生组织及全球疾病负担数据显示,慢性肝病负担大且不断增加,主要因非酒精性脂肪性肝病和酒精相关肝病增加。不同区域受不同病因影响,肝硬化和肝细胞癌增长率因地区和社会人口指数而异。
要点
- 慢性肝病负担全球增加,主要因非酒精性脂肪性肝病和酒精相关肝病。
- 中东、北非和亚洲地区主要受乙型和丙型肝炎病毒影响。
- 肝细胞癌负担因国家和病因不同,中国、韩国、印度、日本和泰国乙型肝炎病毒相关病例最多。
核心结论
- 慢性肝病负担全球增加,但不同区域因社会人口因素影响不同。
研究设计与样本
- 基于世界卫生组织和全球疾病负担已发表数据的综述。
主要发现
- 慢性肝病负担大且增加,主要因非酒精性脂肪性肝病和酒精相关肝病增加。
- 中东、北非和亚洲地区受乙型和丙型肝炎病毒影响最大,中东和北非地区也受非酒精性脂肪性肝病影响,东欧、西非和中亚地区受酒精相关肝病影响。
- 肝硬化增长率在中东以及中高和高社会人口指数地区最高,最高社会人口指数国家肝细胞癌率增加。
- 中国、韩国、印度、日本和泰国乙型肝炎病毒相关肝细胞癌病例最多,中国、日本和美国丙型肝炎病毒相关肝细胞癌病例最多。
- 美国酒精相关肝病相关肝细胞癌病例最多,印度、美国和泰国非酒精性脂肪性肝炎相关肝细胞癌病例最多。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic liver disease (CLD) and its associated complications (cirrhosis and liver cancer) cause significant mortality, morbidity, and economic burden. Published data from the World Health Organization and/or the Global Burden of Disease show that the burden of CLD is large and increasing, primarily owing to the increasing burden of nonalcoholic fatty liver disease and alcohol-related liver disease (ALD). Middle Eastern, Northern African, and Asian regions of the globe are most affected by hepatitis B and hepatitis C virus. Furthermore, Middle Eastern and North African regions also are affected by nonalcoholic fatty liver disease, and Eastern European, West African, and Central Asian regions are affected by ALD. In this context, the rate of increase for cirrhosis is highest in the Middle East, as well as in middle high and high sociodemographic index (SDI) regions. On the other hand, the highest SDI countries are experiencing increasing rates of hepatocellular carcinoma (HCC). Assessing HCC burden based on country and etiology shows that China, Korea, India, Japan, and Thailand have the highest hepatitis B virus-related HCC cases, while China, Japan, and the United States have the highest hepatitis C virus-related HCC cases. Additionally, the United States has the highest ALD-related HCC cases, while India, the United States, and Thailand have the highest nonalcoholic steatohepatitis-related HCC cases. Although the burden of CLD is increasing globally, regions of the world are impacted differently as a result of a number of sociodemographic factors.
引用
- Younossi ZM, Wong G, Anstee QM, et al. The Global Burden of Liver Disease. Clin Gastroenterol Hepatol. 2023. PMID: 37121527. doi:10.1016/j.cgh.2023.04.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。